Ibrutinib, single agent or in combination with dexamethasone, in patients with relapsed or relapsed/refractory multiple myeloma (MM): Preliminary phase 2 results Meeting Abstract
| Authors: | Vij, R.; Huff, C. A.; Bensinger, W. I.; Siegel, D. S.; Jagannath, S.; Berdeja, J.; Lendvai, N.; Lebovic, D.; Anderson, L. D.; Costello, C. L.; Stockerl-Goldstein, K. E.; Laubach, J. P.; Elias, L.; Clow, F.; Fardis, M.; Graef, T.; Bilotti, E.; Richardson, P. G. |
| Abstract Title: | Ibrutinib, single agent or in combination with dexamethasone, in patients with relapsed or relapsed/refractory multiple myeloma (MM): Preliminary phase 2 results |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349243506005 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.31.31 |
| Notes: | Meeting Abstract: 31 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
